UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy
Circulation research, ISSN 0009-7330, 04/2014, Volume 114, Issue 9, pp. 1500 - 1515
Heart failure | myocardial infarction | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Heart Atria - drug effects | Autonomic Nervous System - drug effects | Atrial Fibrillation - therapy | Humans | Risk Factors | Catheter Ablation | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Atrial Fibrillation - physiopathology | Autonomic Nervous System - physiopathology | Autonomic Nervous System - surgery | Heart Atria - surgery | Atrial Function - drug effects | Autonomic Denervation - methods | Action Potentials | Heart Atria - innervation | Animals | Heart Atria - physiopathology | Index Medicus | neuromodulation | Cardiac nerve sprouting | heart failure
Journal Article
Neurology, ISSN 0028-3878, 07/2014, Volume 83, Issue 4, pp. 328 - 335
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cardiology. Vascular system | Neurology | Arterial hypertension. Arterial hypotension | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Clinical manifestations. Epidemiology. Investigative techniques. Etiology | Blood and lymphatic vessels | Humans | Middle Aged | Male | Multiple System Atrophy - complications | Parkinson Disease - drug therapy | Droxidopa - therapeutic use | Posture | Droxidopa - administration & dosage | Time Factors | Female | Pure Autonomic Failure - complications | Blood Pressure - drug effects | Hypotension, Orthostatic - etiology | Parkinson Disease - complications | Autonomic Nervous System Diseases - complications | Double-Blind Method | Hypotension, Orthostatic - drug therapy | Nervous System Diseases - drug therapy | Treatment Outcome | Autonomic Agents - therapeutic use | Autonomic Agents - adverse effects | Nervous System Diseases - complications | Autonomic Agents - administration & dosage | Droxidopa - adverse effects | Dizziness - drug therapy | Autonomic Nervous System Diseases - drug therapy | Multiple System Atrophy - drug therapy | Aged | Pure Autonomic Failure - drug therapy | Index Medicus | Abridged Index Medicus | 172 | 105
Journal Article
3.
Cholinergic neurotransmission
: functional and clinical aspects : proceedings of Nobel Symposium 76
1990, Progress in brain research, ISBN 0444811486, Volume 84., xvii, 493
Book
4.
Full Text
Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease
Nature (London), ISSN 0028-0836, 03/2016, Volume 531, Issue 7592, pp. 105 - 109
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell- and Tissue-Based Therapy - methods | Neurons - pathology | Humans | Colon - drug effects | Drug Discovery - methods | Male | Gastrointestinal Tract - pathology | Pluripotent Stem Cells - pathology | Aging | Female | Cell Differentiation | Neurons - drug effects | Disease Models, Animal | Cell Line | Enteric Nervous System - pathology | Hirschsprung Disease - drug therapy | Signal Transduction | Cell Separation | Colon - pathology | Hirschsprung Disease - pathology | Gastrointestinal Tract - drug effects | Pepstatins - metabolism | Chick Embryo | Cell Lineage | Animals | Hirschsprung Disease - therapy | Mice | Receptor, Endothelin B - metabolism | Cell Movement | Hirschsprung's disease | Care and treatment | Intestine, Small | Cellular therapy | Physiological aspects | Drug discovery | Methods | Nervous system, Autonomic | Studies | Acids | Neurons | Developmental biology | Gastrointestinal diseases | Nervous system | Defects | Index Medicus
Journal Article
Journal of psychiatry & neuroscience, ISSN 1180-4882, 2016, Volume 41, Issue 2, pp. 89 - 104
Psychiatry | Medical Education | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Psychotropic Drugs - adverse effects | Autonomic Nervous System Diseases - complications | Autonomic Nervous System Diseases - physiopathology | Mental Disorders - drug therapy | Autonomic Nervous System Diseases - drug therapy | Humans | Mental Disorders - complications | Mental Disorders - physiopathology | Psychotropic Drugs - therapeutic use | Psychotropic drugs | Psychoses | Drug interactions | Physiological aspects | Dosage and administration | Drug therapy | Observations | Health aspects | Nervous system, Autonomic | Studies | Nervous system | Risk | Index Medicus | Research Paper
Journal Article
Movement disorders, ISSN 0885-3185, 10/2011, Volume 26, Issue S3, pp. S42 - S80
evidence‐based medicine | Parkinson's disease | omega‐3 fatty‐acids | selective serotonin reuptake inhibitors (SSRIs) | transcranial magnetic stimulation | dopamine agonists | tricyclic antidepressants | Transcranial magnetic stimulation | Tricyclic antidepressants | Dopamine agonists | Omega-3 fatty-acids | Selective serotonin reuptake inhibitors (SSRIs) | Evidence-based medicine | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Parkinson Disease - therapy | Mood Disorders - drug therapy | Autonomic Nervous System Diseases - etiology | Sleep Disorders, Intrinsic - etiology | Humans | Sleep Disorders, Intrinsic - drug therapy | Treatment Outcome | Parkinson Disease - drug therapy | Cognition Disorders - drug therapy | Evidence-Based Medicine | Parkinson Disease - psychology | Psychotropic Drugs - therapeutic use | Randomized Controlled Trials as Topic | Antiparkinson Agents - therapeutic use | Mood Disorders - etiology | Mental Disorders - drug therapy | Autonomic Nervous System Diseases - drug therapy | Cognition Disorders - etiology | Mental Disorders - etiology | Index Medicus | evidence-based medicine | omega-3 fatty-acids
Journal Article
European heart journal, ISSN 0195-668X, 05/2012, Volume 33, Issue 9, pp. 1058 - 1066
Renal denervation | Arterial hypertension | Arterial baroreflex | Sympathetic activity | Baroreceptor stimulation | Catecholamines | Beta-blockers | Chronic heart failure | Microneurography | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Arterial hypertension. Arterial hypotension | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Blood and lymphatic vessels | Humans | Sleep Apnea, Obstructive - complications | Equipment Design | Hypertension - etiology | Heart Failure - therapy | Insulin Resistance - physiology | Myocardium - metabolism | Blood Pressure - physiology | Hypertension - therapy | Receptors, Adrenergic, beta - metabolism | Heart Failure - etiology | Adrenergic beta-Antagonists - therapeutic use | Autonomic Nervous System Diseases - complications | Autonomic Nervous System Diseases - metabolism | Electric Stimulation Therapy - instrumentation | Hypertrophy, Left Ventricular - etiology | Prostheses and Implants | Arrhythmias, Cardiac - etiology | Heart Failure - metabolism | Hypertension - metabolism | Catheter Ablation - methods | Autonomic Nervous System Diseases - therapy | Norepinephrine - metabolism | Kidney Failure, Chronic - complications | Catheter Ablation - instrumentation | Baroreflex - physiology | Index Medicus | Drugs | Hypertension | Baroreceptors | Translation | Antihypertensives | Central nervous system | Clinical trials | Drug development | Sympathetic nervous system | Kidney | Reviews | Developmental stages | Blood pressure | Heart diseases | sympathetic nerves | Renal nerve | Denervation | imidazoline
Journal Article